STAAR Surgical (STAA) Tops Q2 EPS by 2c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
STAAR Surgical Reports Second Quarter 2026 Results
August 12, 2026 4:01 PM EDTNet Sales of $93.5 million, up 111% Y/Y
Net Income of $8.1 million, with GAAP EPS of $0.16
Adjusted EBITDA1 of $20.0 million, or $0.39 per diluted share
Earnings Call and Webcast Today at 5:30 PM Eastern
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today reported results for the second quarter ended July 3, 2026.
Second Quarter 2026... More
